On examination of a breast mass surgically excised in a 69-years-old woman, a pure invasive micropapillary carcinoma (MPC) was diagnosed ([Figure 1](#fig1-1066896915605616){ref-type="fig"}). At close examination, intensely eosinophilic syncytial-multinucleated giant cells (CD68+) percolating the stromal bands were identified ([Figure 1](#fig1-1066896915605616){ref-type="fig"}). The breast carcinoma illustrated here shows therefore a combination of 2 rarities, namely, an invasive micropapillary growth pattern and an osteoclast-like giant cell (OGC) component. The World Health Organization blue book classifies the "carcinoma with osteoclast-like stromal giant cells" among rare variants of invasive carcinomas of no special type (IC-NSTs)^[@bibr1-1066896915605616]^; however, OGCs can also accompany a variety of breast cancer special types (cribriform, tubular, mucinous, papillary, lobular, squamous and other metaplastic patterns^[@bibr1-1066896915605616],[@bibr2-1066896915605616]^). Identification of giant cells populating MPCs can be challenging as they feature the same size as the micropapillae and only differ in staining (more eosinophilic cytoplasm) ([Figure 1](#fig1-1066896915605616){ref-type="fig"}).

![Micropapillary carcinoma of the breast with an osteoclast-like giant cell component. Pure invasive micropapillary carcinoma: neoplastic cells are arranged in small cell clusters immersed in a spongy stroma (A), showing the so-called "inverted polarity" (MUC1 expression lining the stroma-facing border of the morulae) (B). Intensely eosinophilic syncytial-multinucleated giant cells of histiocytic origin (CD68+, MUC1−) percolating the stromal bands (A, C). Following review of cytological specimens of presurgical diagnosis, multinucleated giant cells scattered among small cell clusters of neoplastic cells were also identified (D).](10.1177_1066896915605616-fig1){#fig1-1066896915605616}

Osteoclast-like giant cells are hypothesized to derive from macrophages by syncytial fusion but not by mitosis without cell division^[@bibr3-1066896915605616]^; however, the mechanism of OGC formation and accumulation in breast carcinoma is still largely unknown.^[@bibr2-1066896915605616]^ An open question remains about their prognostic significance: a study on metaplastic carcinomas with an OGC component reported a 5-year survival rate fairly similar to that of patients affected by IC-NST.^[@bibr1-1066896915605616]^ Further studies on large cohorts would be needed to definitely ascertain whether or not a diagnosis of breast carcinoma with osteoclast-like stromal giant cells may affect patient clinical outcome.^[@bibr1-1066896915605616]^
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